Relmada Therapeutics (RLMD) Return on Assets [ROA] (2013 - 2026)
Relmada Therapeutics' Return on Assets [ROA] was -26.95% in Q2 2026, up 252.79 percentage points from -279.74% a year earlier and up 8.53 percentage points from the prior quarter.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Return on Assets [ROA] (2013 - 2026) Analysis & Trends
For FY2025, Return on Assets [ROA] at Relmada Therapeutics came in at -82.54%, up 29.56 percentage points from FY2024.
- Return on Assets [ROA] shows a five-year change of -30.83 percentage points (FY2020 to FY2025).
- In earlier years, Return on Assets [ROA] was -112.10% in FY2024 (-33.41 pp), -78.70% in FY2023 (+7.02 pp), -85.72% in FY2022 (-12.10 pp) and -73.62% in FY2021 (-21.91 pp).
- The Q2 2026 figure marks the highest quarterly Return on Assets [ROA] since Q2 2020.
- Compared with a year earlier, Return on Assets [ROA] has increased for three straight quarters, with an average year-over-year change of -9.28 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Assets [ROA] over five years was Q2 2026 (a gain of 252.79 percentage points); the worst was Q3 2025 (a drop of 174.09 percentage points).
- Per Business Quant data, RLMD's Return on Assets [ROA] in the three quarters before Q2 2026 was -35.48% (Q1 2026), -106.00% (Q4 2025) and -312.17% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | Relmada Therapeutics | 455.48 Mn | -103.11 Mn | - | -26.95% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -26.95% |
| Mar 31, 2026 | -35.48% |
| Dec 31, 2025 | -106.00% |
| Sep 30, 2025 | -312.17% |
| Jun 30, 2025 | -279.74% |
| Mar 31, 2025 | -207.37% |
| Dec 31, 2024 | -158.28% |
| Sep 30, 2024 | -138.08% |
| Jun 30, 2024 | -111.59% |
| Mar 31, 2024 | -102.81% |
| Dec 31, 2023 | -95.36% |
| Sep 30, 2023 | -95.65% |
| Jun 30, 2023 | -98.68% |
| Mar 31, 2023 | -102.31% |
| Dec 31, 2022 | -93.28% |
| Sep 30, 2022 | -76.96% |
| Jun 30, 2022 | -72.23% |
| Mar 31, 2022 | -62.56% |
| Dec 31, 2021 | -79.24% |
| Sep 30, 2021 | -110.24% |
API Access
Relmada Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();